Infratil (NZX:IFT): Is there an increase in its CDC investment?

January 05, 2022 03:45 PM NZDT

Be the First to Comment

Sonal

Author

Sonal - Research Editor
868 Posts
Sonal is a Research Analyst at Kalkine Media Pty Ltd. She has done M.Sc. in Economics from Shiv Nadar University and B.A. Economic (Honours) from Lady Shri Ram College, Delhi University. She has over 3 years of diverse experience in economic policy a...
Follow

Infratil (NZX:IFT): Is there an increase in its CDC investment? — Image source: Bannafarsai_Stock, Shutterstock.com

Highlights

Infratil has declared that its value of investment in CDC Data Centres has risen by 15%.

CDC has 4 data centres that are under construction.

Infratil Limited (NZX:IFT; ASX:IFT) revealed on Wednesday that the value of its stake in CDC Data Centres has increased by 15% in previous 6 months. The infrastructure investor firm announced that its 48% stake in CDC is now anticipated to be between A$2.669 billion and A$2.862 billion.

This shows robust customer interest in CDC’s services and greater development is on the way. CDC has 4 data centres under construction across 3 geographies- Canberra, Auckland and Sydney that totals 104MW capacity.

Source: © Ml12nan | Megapixl.com

CDC also has plans to expand to Melbourne with the first period of construction likely to start shortly. This would increase its capacity by 150MW to its existing development pipeline.

The Company has informed that its FY22 International Portfolio Annual Incentive Fee will be NZ$70 million, a rise of NZ$60 million since the accrual as on 30 September 2021.

Infratil also notified that there was no change in CDC’s guidance for FY22.

On 5 January, at the time of writing, IFT was trading at NZ$8.24, up 3%.

Bottom Line

The valuation increase and CDC’s track record as well as customer demand, are offering certainty in the medium-term growth prospects.